drugset / Trial / NCT06758544
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer
Phase 1/2
Recruiting
18 enrolled
Guangdong Provincial People's Hospital
Guangzhou Virotech Pharmaceutical Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, single-arm, open investigator-initiated clinical study to evaluate the efficacy and safety of VRT106 in combination with chemotherapy in the treatment of resectable pancreatic cancer.
Timeline
- Start
- 2025-03-17
- Primary completion
- 2026-09-30
- Completion
- 2026-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VRT106 | Unknown | — | Intravenous |